Evidence map›Paper›PMID 33592037›Full record

ArticlePloS one2021

The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment.

Juliet A Usher-Smith, Katie M Mills, Christiane Riedinger, Catherine L Saunders, Lise M Helsingen, Lyubov Lytvyn, Maaike Buskermolen, Iris Lansdorp-Vogelaar, Michael Bretthauer, Gordon Guyatt and 1 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An education resource for human papillomavirus oropharyngeal cancer patients: think-aloud interviews.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  7. A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  8. Behavioural Challenges Associated With Risk-Adapted Cancer Screening.Cancer control : journal of the Moffitt Cancer Center
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Juliet A Usher-SmithThe Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-8501-2531
Katie M MillsThe Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Christiane RiedingerThe Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Catherine L SaundersThe Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Lise M HelsingenClinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, and Institute of Health and Society, University of Oslo, Oslo, Norway.
Lyubov LytvynDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Maaike BuskermolenDepartment of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Iris Lansdorp-VogelaarDepartment of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Michael BretthauerClinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, and Institute of Health and Society, University of Oslo, Oslo, Norway.
Gordon GuyattDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Simon J GriffinThe Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2157-4797

Funding

Cancer Research UK 21464Cancer Research UK C55650/A21464Department of HealthMedical Research Council MC_UU_00006/6
6 · The paper itself

Abstract

backgroundThere is considerable heterogeneity in individuals' risk of disease and thus the absolute benefits and harms of population-wide screening programmes. Using colorectal cancer (CRC) screening as an exemplar, we explored how people make decisions about screening when presented with information about absolute benefits and harms, and how those preferences vary with baseline risk, between screening tests and between individuals.

methodWe conducted two linked studies with members of the public: a think-aloud study exploring decision making in-depth and an online randomised experiment quantifying preferences. In both, participants completed a web-based survey including information about three screening tests (colonoscopy, sigmoidoscopy, and faecal immunochemical testing) and then up to nine scenarios comparing screening to no screening for three levels of baseline risk (1%, 3% and 5% over 15 years) and the three screening tests. Participants reported, after each scenario, whether they would opt for screening (yes/no).

resultsOf the 20 participants in the think-aloud study 13 did not consider absolute benefits or harms when making decisions concerning CRC screening. In the online experiment (n = 978), 60% expressed intention to attend at 1% risk of CRC, 70% at 3% and 77% at 5%, with no differences between screening tests. At an individual level, 535 (54.7%) would attend at all three risk levels and 178 (18.2%) at none. The 27% whose intention varied by baseline risk were more likely to be younger, without a family history of CRC, and without a prior history of screening.

conclusionsMost people in our population were not influenced by the range of absolute benefits and harms associated with CRC screening presented. For an appreciable minority, however, magnitude of benefit was important.

Indexed as

Cost-Benefit AnalysisDecision MakingIntentionInternetColorectal NeoplasmsFemaleHumansMaleMass ScreeningMiddle AgedSurveys and Questionnaires

Identifiers

PMID33592037
PMCPMC7886213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.